CureMatch Names Life Sciences Executive David Szekeres as Board Director
CureMatch, Inc., a healthcare technology company that leverages artificial intelligence (AI) to power precision medicine support for oncology, announced today that David Szekeres has been named board director. Mr. Szekeres is a seasoned executive with over 20 years in the life sciences industry, with deep operational, commercial, corporate development, strategy, financial, investor relations, and legal expertise.
Mr. Szekeres has extensive experience in developing and executing biotechnology growth strategies with expertise….Read More